FSFlavia Eliana Santiano

Flavia Eliana Santiano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Flavia Eliana Santiano has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Ruben Walter Carón

    Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), Centro Científico y Tecnológico Mendoza, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Cuyo, Mendoza CP5500, Argentina

    4 shared publications
  • Constanza Matilde López-Fontana

    Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), Centro Científico y Tecnológico Mendoza, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Cuyo, Mendoza CP5500, Argentina

    3 shared publications
  • Corina Verónica Sasso

    Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), Centro Científico y Tecnológico Mendoza, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Mendoza, Argentina

    3 shared publications
  • Virginia Pistone-Creydt

    Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), Centro Científico y Tecnológico Mendoza, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Mendoza, Argentina

    2 shared publications
  • Constanza M. López-Fontana

    Laboratory of Hormones and Biology of Cancer, Institute of Medicine and Experimental Biology of Cuyo (IMBECU), CONICET, CCT-Mendoza, Avenida Adrián Ruiz-Leal s/n, CC855, 5500 Mendoza, Argentina

    1 shared publication
  • Constanza Matilde López‐Fontana

    Laboratory of Hormones and Cancer Biology Institute of Medicine and Experimental Biology of Cuyo (IMBECU), National Scientific and Technical Research Council (CONICET UNCuyo) Mendoza Argentina

    1 shared publication

Latest Publications

  • Inpatient and outpatient treatment by specialist infant nutrition centres in Argentina effectively reduced child malnourishment

    by Flavia Eliana Santiano, Juan Manuel Fernandez‐Muñoz, Virginia Pistone‐Creydt, Felipe Carlos Martín Zoppino, Constanza Matilde López‐Fontana, Rubén Walter Carón

    Aim: We evaluated the impact of inpatient and outpatient treatment provided by an infant nutrition foundation in Las Heras, Mendoza, Argentina and identified the factors that influenced nutritional recovery.Methods: This 2010–2018 retrospective study was based on 300 children up to 5 years of age with primary malnutrition, who were treated by an inpatient recovery centre, then an outpatient prevention centre. We analysed the children's height, weight, psychomotor development and living conditions when they were admitted, discharged and had received 1 year of outpatient treatment. There were full data on 241 children and just admission and discharge data for 59.Results: The children's mean age on admission and weight were 14.8 ± 12.4 months and 6.9 ± 2.3 kg and they stayed in hospital for a mean of 59.5 ± 49.7 days. We observed a significant increase in the weight‐for‐age, height‐for‐age and weight‐for‐height z‐scores when all three time points were compared (p < 0.001). Psychomotor development improved considerably in all patients after treatment. The factors that negatively influenced nutritional recovery were higher age at admission, suboptimal breastfeeding practices, low birth weight, longer hospital stays, younger maternal age and overcrowded housing.Conclusion: Combining inpatient recovery and outpatient preventive treatment was effective for undernourished children in Argentina.


  • Protective effects of Yerba mate (IIex paraguariensis) on prostate cancer development

    by Flavia E. Santiano, María de Los Ángeles Fernández, Magdalena Espino, Leila E. Zyla, Lara Rey, Silvina E. Gómez, Flavia A. Bruna, Virginia Pistone-Creydt, Elisa Pietrobon, Rafael Pérez Elizalde, et al.


  • Effects of hypothyroidism on the mesenteric and omental adipose tissue in rats

    by C.M. López-Fontana, G. Pennacchio, L.E. Zyla, J. Toneatto, F.A. Bruna, N. Ortiz, P.L. Sassi, F.E. Santiano, S. García, C.V. Sasso, et al.


  • Open Access

    Human breast adipose tissue: characterization of factors that change during tumor progression in human breast cancer

    by Sabrina Johanna Fletcher, Paula Alejandra Sacca, Mercedes Pistone-Creydt, Federico Andrés Coló, María Florencia Serra, Flavia Eliana Santino, Corina Verónica Sasso, Constanza Matilde Lopez-Fontana, Rubén Walter Carón, Juan Carlos Calvo, et al.

    Adipose microenvironment is involved in signaling pathways that influence breast cancer. We aim to characterize factors that are modified: 1) in tumor and non tumor human breast epithelial cell lines when incubated with conditioned media (CMs) from human breast cancer adipose tissue explants (hATT) or normal breast adipose tissue explants (hATN); 2) in hATN-CMs vs hATT-CMs; 3) in the tumor associated adipocytes vs. non tumor associated adipocytes. We used hATN or hATT- CMs on tumor and non-tumor breast cancer cell lines. We evaluated changes in versican, CD44, ADAMTS1 and Adipo R1 expression on cell lines or in the different CMs. In addition we evaluated changes in the morphology and expression of these factors in slices of the different adipose tissues. The statistical significance between different experimental conditions was evaluated by one-way ANOVA. Tukey’s post-hoc tests were performed within each individual treatment. hATT-CMs increase versican, CD44, ADAMTS1 and Adipo R1 expression in breast cancer epithelial cells. Furthermore, hATT-CMs present higher levels of versican expression compared to hATN-CMs. In addition, we observed a loss of effect in cellular migration when we pre-incubated hATT-CMs with chondroitinase ABC, which cleaves GAGs chains bound to the versican core protein, thus losing the ability to bind to CD44. Adipocytes associated with the invasive front are reduced in size compared to adipocytes that are farther away. Also, hATT adipocytes express significantly higher amounts of versican, CD44 and Adipo R1, and significantly lower amounts of adiponectin and perilipin, unlike hATN adipocytes. We conclude that hATT secrete a different set of proteins compared to hATN. Furthermore, versican, a proteoglycan that is overexpressed in hATT-CMs compared to hATN-CMs, might be involved in the tumorogenic behavior observed in both cell lines employed. In addition, we may conclude that adipocytes from the tumor microenvironment show a less differentiated state than adipocytes from normal microenvironment. This would indicate a loss of normal functions in mature adipocytes (such as energy storage), in support of others that might favor tumor growth.


  • Open Access

    Effects of Parity and Serum Prolactin Levels on the Incidence and Regression of DMBA-Induced Tumors in OFA hr/hr Rats

    by Corina V. Sasso, Flavia E. Santiano, Constanza M. López-Fontana, Virginia Pistone-Creydt, Marcelo E. Ezquer, María B. Hapon, Graciela A. Jahn, Rubén W. Carón

    Prolactin (PRL) is a key player in the development of mammary cancer. We studied the effects of parity or hyperprolactinemia on mammary carcinogenesis in OFA hr/hr treated with 7,12-dimethylbenzanthracene. They were divided into three groups: nulliparous (Null), primiparous (PL, after pregnancy and lactation), and hyperprolactinemic rats (I, implanted in the arcuate nucleus with 17β-estradiol). The tumor incidence was similar in the three groups. However, a higher percentage of regressing tumors was evident in the PL group. Serum PRL, mammary development, and mammaryβ-casein content were higher in I rats compared to Null. The expression of hormone receptors was similar in the different groups. However, mammary tissue from PL rats bearing tumors had increased expression of PRL and estrogen alpha receptors compared to rats free of tumors. Our results suggest that serum PRL levels do not have relevance on the incidence of tumors, probably because the low levels of PRL in OFA rats are not further decreased by PL like in other strains. However, supraphysiological levels of PRL affect carcinogenesis. PL induces regression of the tumors due to the differentiation produced on the mammary cells. Alterations in the expression of hormonal receptors may be involved in progression and regression of tumors.